Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella

Vaccine

Volumn 21, Issue 7-8, 2003, Pages 644-648

  Xu, Fengfeng ^a   Hong, Mei ^a   Ulmer, Jeffrey B ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

DNA vaccine; HIV gag; Shigella

Indexed keywords

BACTERIAL PROTEIN; DNA VACCINE; GAG PROTEIN; NAKED DNA; PLASMID VECTOR; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BACTERIAL CELL; BACTERIUM MUTANT; CONFERENCE PAPER; CONTROLLED STUDY; DNA VECTOR; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; MAMMAL CELL; MICROBIAL ATTENUATION; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE; SHIGELLA FLEXNERI;

AIDS VACCINES; ANIMALS; FEMALE; GENE PRODUCTS, GAG; HIV-1; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED STRAINS; SHIGELLA FLEXNERI; VACCINES, ATTENUATED; VACCINES, DNA;

EID: 0037472434     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00573-X     Document Type: Conference Paper

References (26)

1. Schaffner W. Direct transfer of cloned genes from bacteria to mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 77:1980;2163-2167.
2. Courvalin P., Goussard S., Grillot-Couvalin C. Gene transfer from bacteria to mammalian cells. C. R. Acad. Sci. 318:1995;1207-1212.
3. Sizemore D.R., Branstrom A.A., Sadoff J.C. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science. 270:1995;299-302.
4. Shata M.T., Stevceva L., Agwale S., Lewis G.K., Hone D.M. Recent advances with recombinant bacterial vaccine vectors. Mol. Med. Today. 6:2000;66-71.
5. Dietrich G., Gentschev I., Hess J., Ulmer J.B., Kaufmann S.H., Goebbel W. Delivery of DNA vaccines by attenuated intracellular bacteria. Immunol. Today. 20:1999;251-253.
6. Berzofsky J.A., Ahlers J.D., Derby M.A., Pendleton C.D., Arichi T., Belyakov I.M. Approaches to improve engineered vaccines for human immunodeficiency virus (HIV) and other viruses that cause chronic infections. Immunol. Rev. 170:1999;151-172.
7. Lehner T., Bergmeier L., Wang Y., Tao L., Mitchell E. A rational basis for mucosal vaccination against HIV infection. Immunol. Rev. 170:1999;183-196.
8. Shata M.T., Hone D.M. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8+ T cells and antiviral protective immunity. J. Virol. 75:2001;9665-9670.
9. Vecino W.H., Morin P.M., Agha R., Jacobs W.R., Fennelly G.J. Mucosal DNA vaccination with highly attenuated Shigella is superior to attenuated Salmonella and comparable to intramuscular DNA vaccination for T cells against HIV. Immunol. Lett. 82:2002;197-202.
10. Hong M., Payne S.M. Effect of mutations in Shigella flexneri chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance. Mol. Microbiol. 24:1997;779-791.
11. Hong M., Gleason Y., Wyckoff E.E., Payne S.M. Identification of two Shigella flexneri chromosomal loci involved in intercellular spreading. Infect. Immunol. 66:1998;4700-4710.
12. Cersini A., Salvia A.M., Bernardini M.L. Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. Infect. Immunol. 66:1998;549-557.
13. Bardwell J.C., McGovern K., Beckwith J. Identification of a protein required for disulfide bond formation in vivo. Cell. 67:1991;581-589.
14. zur Megede J., Chen M.C., Doe B., Schaefer M., Greer C.E., Selby M.et al. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene. J. Virol. 74:2000;2628-2635.
15. Muesing M., Tamm J., Shepard H.M., Polisky B. A single base-pair alteration is responsible for the DNA overproduction phenotype of a plasmid copy-number mutant. Cell. 24:1981;235-242.
16. Gentschev I., Sokolovic Z., Mollenkopf H.J., Kaufmann S.H., Kuhn M., Krohne G.F.et al. Salmonella strain secreting active listeriolysin changes its intracellular localization. Infect. Immunol. 63:1995;4202-4205.
17. Hess J., Gentschev I., Miko D., Welzel M., Ladel C., Goebel W.et al. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1458-1463.
18. Fortier AH, Falk LA. Isolation of murine macrophage. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. Current protocol of immunology. New York: Wiley; 1998. p. 14.1.1.
19. Murayama S.Y., Sakai T., Makino S., Kurata T., Sasakawa C., Yoshikawa M. The use of mice in the Sereny test as a virulence assay of Shigella and enteroinvasive Escherichia coli. Infect. Immunol. 51:1986;696-698.
20. Yu J. Inactivation of DsbA, but not DsbC and DsbD, affects the intracellular survival and virulence of Shigella flexneri. Infect. Immunol. 66:1998;3909-3917.
21. Sereny B. Experimental keratoconjunctivitis shigellosa. Acta Microbiol. Acad. Sci. Hung. 4:1957;367-376.
22. Mallett C.P., van de Verg L., Collins H.H., Hale T.L. Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model. Vaccine. 11:1993;190-196.
23. van de Verg L.L., Mallet C.P., Collins H.H., Larsen T., Hammack C., Hale T.L. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection. Infect. Immunol. 63:1995;1947-1954.
24. Newman M.J. Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses. Curr. Opin. Invest. Drugs. 3:2002;374-378.
25. Darji A., Guzman C.A., Gerstel B., Wachholz P., Timmis K.N., Wehland J.et al. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell. 91:1997;765-775.
26. Fennelly G.J., Khan S.A., Abadi M.A., Wild T.F., Bloom B.R. Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. J. Immunol. 162:1999;1603-1610.